AIM: To assess the anti-cancer effect of lobaplatin on human gastric cancer cells, and to explore the underlying molecular mechanisms. METHODS: The human gastric cancer cell lines MKN-28, AGS and MKN-45 were used. The cytotoxicity of lobaplatin was detected using an MTS cell proliferation assay. Flow cytometry was used to detect cell apoptosis using Annexin V-FITC Apoptosis Detection Kit. The expression of apoptosis-regulated genes was examined at the protein level using Western blot. RESULTS: Lobaplatin inhibited the proliferation of human gastric cancer cells and induced apoptosis, which may be associated with the up-regulation of Bax expression, poly(ADP-ribose) polymerase (PARP) cleavage, p53 expression and the reduction of Bcl-2 expression. CONCLUSION: The cytotoxicity of lobaplatin may be due to its ability of inducing apoptosis of gastric cancer cells, which would support the potential use of lobaplatin for the therapy of gastric cancer.
AIM: To assess the anti-cancer effect of lobaplatin on humangastric cancer cells, and to explore the underlying molecular mechanisms. METHODS: The humangastric cancer cell lines MKN-28, AGS and MKN-45 were used. The cytotoxicity of lobaplatin was detected using an MTS cell proliferation assay. Flow cytometry was used to detect cell apoptosis using Annexin V-FITC Apoptosis Detection Kit. The expression of apoptosis-regulated genes was examined at the protein level using Western blot. RESULTS:Lobaplatin inhibited the proliferation of humangastric cancer cells and induced apoptosis, which may be associated with the up-regulation of Bax expression, poly(ADP-ribose) polymerase (PARP) cleavage, p53 expression and the reduction of Bcl-2 expression. CONCLUSION: The cytotoxicity of lobaplatin may be due to its ability of inducing apoptosis of gastric cancer cells, which would support the potential use of lobaplatin for the therapy of gastric cancer.
Authors: Kelly A Avery-Kiejda; Nikola A Bowden; Amanda J Croft; Lyndee L Scurr; Carla F Kairupan; Katie A Ashton; Bente A Talseth-Palmer; Helen Rizos; Xu D Zhang; Rodney J Scott; Peter Hersey Journal: BMC Cancer Date: 2011-05-27 Impact factor: 4.430
Authors: Wuguo Tian; Shuai Hao; Bo Gao; Yan Jiang; Xiaohua Zhang; Shu Zhang; Lingji Guo; Jianjie Zhao; Gang Zhang; Yi Chen; Zhirong Li; Donglin Luo Journal: Drug Des Devel Ther Date: 2018-10-29 Impact factor: 4.162